Calidi Biotherapeutics
CLDI
CLDI
26 hedge funds and large institutions have $40.6M invested in Calidi Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.01% more ownership
Funds ownership: 0.79% → 0.8% (+0.01%)
Holders
26
Holding in Top 10
1
Calls
$622K
Puts
–
Top Buyers
| 1 | +$3.85M | |
| 2 | +$1.43M | |
| 3 | +$1.1M | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$201K |
| 5 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$183K |
Top Sellers
| 1 | -$4.07M | |
| 2 | -$1.22M | |
| 3 | -$954K | |
| 4 |
E
Ergoteles
New York
|
-$416K |
| 5 |
EC
Elequin Capital
New York
|
-$2.46K |